Lyell Immunopharma, Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

Compare

16.51

-2.36 (-12.51%)

At close: Oct 10, 2025, 4:00 PM EDT

16.31

-0.20 (-1.21%)

After-hours: Oct 10, 2025, 7:46 PM EDT

Lyell Immunopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	98.8	105.6	145.65	123.55	293.83	140.41
Short-Term Investments	177.99	264.93	400.58	516.6	320.97	472.21
Cash & Short-Term Investments	276.79	370.53	546.22	640.15	614.79	612.62
Cash Growth	-43.64%	-32.17%	-14.67%	4.13%	0.36%	-
Other Current Assets	5.42	9.07	8.46	11.14	11.49	4.93
Total Current Assets	282.21	379.59	554.69	651.3	626.29	617.55
Net Property, Plant & Equipment	60.07	72.94	142.32	166.27	166.64	124.06
Long-Term Investments	39.06	32.01	48.51	115.04	330.53	163.44
Other Long-Term Assets	4.11	6.31	4.52	4.96	3.95	3.24
Total Assets	385.45	490.86	750.03	937.56	1,127	908.28
Accounts Payable	3.38	5.37	4.82	3.92	3.21	9.4
Accrued Expenses	28	40.82	28.13	28.76	29.06	28.02
Unearned Revenue	-	-	-	-	4.99	6.1
Other Current Liabilities	5.53	7.6	1.58	4.36	9.49	5.77
Total Current Liabilities	36.9	53.79	34.52	37.03	46.74	49.29
Long-Term Leases	46.6	50.99	56.89	63.17	66.65	50.96
Other Long-Term Liabilities	3.03	3.25	3.66	4.11	84.23	89.6
Total Long-Term Liabilities	49.63	54.25	60.56	67.28	150.88	140.56
Total Liabilities	86.53	108.04	95.08	104.31	197.62	189.84
Preferred Stock	-	-	-	-	-	1,011
Common Stock	0	0	0.03	0.03	0.02	0
Additional Paid-in Capital	1,739	1,728	1,657	1,608	1,516	41.36
Accumulated Other Comprehensive Income	0.06	0.29	-0.09	-7.6	-1.62	0.26
Retained Earnings	-1,440	-1,345	-1,002	-767.48	-584.36	-334.14
Shareholders' Equity	298.92	382.82	654.95	833.25	929.79	-292.53
Total Liabilities & Equity	385.45	490.86	750.03	937.56	1,127	908.28
Total Debt	46.6	50.99	56.89	63.17	66.65	50.96
Net Cash (Debt)	230.19	319.53	489.33	576.98	548.14	561.66
Net Cash Growth	-27.96%	-34.70%	-15.19%	5.26%	-2.41%	-
Net Cash Per Share	16.34	24.44	38.99	46.70	80.66	847.28
Book Value	298.92	382.82	654.95	833.25	929.79	-292.53
Book Value Per Share	21.21	29.28	52.19	67.45	136.82	-441.29
Tangible Book Value	298.92	382.82	654.95	833.25	929.79	-292.53
Tangible Book Value Per Share	21.21	29.28	52.19	67.45	136.82	-441.29

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q